0
Letters |

Gene-Environment Interactions and Depression

Karestan C. Koenen, PhD; Sandro Galea, MD, DrPH
JAMA. 2009;302(17):1859-1862. doi:10.1001/jama.2009.1575
Text Size: A A A
Published online

To the Editor: In their meta-analysis, Dr Risch and colleagues1 concluded that the study of gene-environment interaction in mental disorders should await the identification of “robust marginal gene associations.” We believe that this conclusion extends well beyond the data, and an alternate explanation of their findings suggests other courses of action. The absence of replicable findings across studies that assessed both direct genotype-depression associations and gene-environment interactions may be explained by mismeasurement and undermeasurement of relevant environmental contexts.

Two compelling strands of evidence support this hypothesis. First, there is a sharp contrast in the consistency of success in studies that have sought genotype-phenotype associations in animals and in humans. For example, animal models of depression and anxiety disorders have consistently demonstrated genotype-phenotype associations.2 By contrast, a recent genome-wide association study (GWAS) of depression found no significant associations.3 One central difference between these 2 research approaches lies in control over potentially relevant environmental exposures. These exposures are effectively randomized in animal models, but such control is absent from observational human gene-hunting studies.

Second, outside the gene-environment literature reviewed by Risch et al,1 the evidence for environmental modification of genetic effects on human behavior is robust and increasing. The heritability of many phenotypes is modified by environmental factors such as socioeconomic status.4 Genotype-phenotype associations are also modified by context familiarity in animal models2 and features of social environments in human studies.5 Unmeasured aspects of environmental context could contribute to nonreplication of gene-environment findings that at best limit the measurement of environment to life events.

Rather than conducting less research on how genotype and a range of environmental factors jointly produce mental disorders, what is needed is more and better-quality research. Unfortunately, to date GWAS of mental disorders have exclusively tested for genetic main effects, and gene-environment interaction studies have focused on candidate genes and individual-level measures of environmental exposures. Genome-wide association studies of mental disorders may produce more robust findings if populations were sampled conditional on exposure to a range of plausible environmental risk factors. Gene-environment interaction studies would benefit from moving away from focus on single candidate genes and toward considering multiple levels of environmental exposures.

Studies that integrate state-of-the-science methods of measurement of both genetic and environmental factors will provide a more comprehensive test of the role of gene-environment interaction in mental disorders than a meta-analysis of a single gene–environmental risk factor disorder association.

AUTHOR INFORMATION

Financial Disclosures: None reported.

REFERENCES

Risch N, Herrell R, Lehner T,  et al.  Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.  JAMA. 2009;301(23):2462-2471
PubMedCrossRef
Kalin NH, Shelton SE, Fox AS, Rogers J, Oakes TR, Davidson RJ. The serotonin transporter genotype is associated with intermediate brain phenotypes that depend on the context of eliciting stressor.  Mol Psychiatry. 2008;13(11):1021-1027
PubMedCrossRef
Muglia P, Tozzi F, Galwey NW,  et al.  Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts [published online December 23, 2008].  Mol Psychiatrydoi:
CrossRef

PubMed
Plomin R, DeFries JC, McClearn GE, McGuffin P. Behavioral Genetics. 5th ed. New York, NY: Worth Publishers; 2008
Koenen KC, Aiello AE, Bakshis E,  et al.  Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment.  Am J Epidemiol. 2009;169(6):704-711
PubMedCrossRef

First Page Preview

First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

Risch N, Herrell R, Lehner T,  et al.  Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis.  JAMA. 2009;301(23):2462-2471
PubMedCrossRef
Kalin NH, Shelton SE, Fox AS, Rogers J, Oakes TR, Davidson RJ. The serotonin transporter genotype is associated with intermediate brain phenotypes that depend on the context of eliciting stressor.  Mol Psychiatry. 2008;13(11):1021-1027
PubMedCrossRef
Muglia P, Tozzi F, Galwey NW,  et al.  Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts [published online December 23, 2008].  Mol Psychiatrydoi:
CrossRef

PubMed
Plomin R, DeFries JC, McClearn GE, McGuffin P. Behavioral Genetics. 5th ed. New York, NY: Worth Publishers; 2008
Koenen KC, Aiello AE, Bakshis E,  et al.  Modification of the association between serotonin transporter genotype and risk of posttraumatic stress disorder in adults by county-level social environment.  Am J Epidemiol. 2009;169(6):704-711
PubMedCrossRef
November 4, 2009
Francis E. Lotrich, MD, PhD; Eric Lenze, MD
JAMA. 2009;302(17):1859-1862.
November 4, 2009
Christian Schwahn, PhD; Hans Jörgen Grabe, MD
JAMA. 2009;302(17):1859-1862.
November 4, 2009
Nina Rieckmann, PhD; Michael A. Rapp, MD, PhD; Jacqueline Müller-Nordhorn, MD, DPH
JAMA. 2009;302(17):1859-1862.
November 4, 2009
Kathleen Ries Merikangas, PhD; Thomas Lehner, PhD; Neil J. Risch, PhD
JAMA. 2009;302(17):1859-1862.
CME Course for:


You need to register in order to view this quiz.


To understand the clinical management of acute heart failure syndromes.
Accreditation Information The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
To view and print your certificate and access a summary of your CME courses go to My CME.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.